对耐药结核病患者面临的身体,社会,心理和环境挑战的定量研究
Tushar Sahasrabudhe1, Mithun Nilgiri K1
1Respiratory Medicine, Dr. D. Y. Patil Medical College, Hospital & Research Centre, Dr. D. Y. Patil Vidyapeeth, Pune, IND.
Cureus
|October 22, 2024
概括
耐药结核病 (DR-TB) 对患者产生重大影响.
科学领域:
- 公共卫生 公共卫生
- 传染性疾病 传染性疾病
- 生活质量研究 研究 生命质量研究
背景情况:
- 印度面临着世界上最高的结核病 (TB) 负担,耐药结核病 (DR-TB) 构成了重大挑战.
- 现有的国家结核病消除计划 (NTEP) 措施需要扩大,以应对DR-TB的社会经济和情感损失.
研究的目的:
- 评估DR-TB及其治疗对患者在心理,社会,环境和身体领域的生活质量的影响.
- 确定印度DR-TB患者面临的具体挑战.
主要方法:
- 一项定量研究在浦那的一家三级护理中心进行.
- 世界卫生组织的生活质量 (WHOQOL-BREF) 调查问卷对64名耐药结核病患者进行了管理.
- 数据收集涉及自我管理与调查人员的协助.
主要成果:
- 在心理 (平均33.41) 和社会 (平均35.52) 领域,DR-TB患者报告生活质量最低.
- 物理 (平均41.88) 和环境 (平均41.27) 领域也显示出显著的影响.
- 患者经历了相当大的就业挑战,经济困难,以及对疾病传播的恐惧.
结论:
- 整体干预至关重要,整合了对DR-TB患者的心理支持和社会经济赋权.
- 与临床护理一起解决心理社会需求对于改善生活质量和治疗坚持是必不可少的.
- 需要加强政策和资源配置,以全面的DR-TB管理,重点关注发病率和患者福祉.
关键词:
耐药结核病 (dr-tb) 是一种心理健康 心理健康国家消除结核病计划 (ntep)心理测量评估 心理测量评估公共卫生公共卫生.生活质量 (qol) 生活质量 (qol)社交互动 社交互动经济社会面临的挑战.谁可以说-breff.更多相关视频
相关概念视频
Pulmonary Tuberculosis V
170
Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
170
Pulmonary Tuberculosis I
220
Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
220
Pulmonary Tuberculosis IV
134
Tuberculosis, more commonly referred to as TB, is an infectious disease stemming from Mycobacterium tuberculosis. While it primarily impacts the lungs, TB can also affect other body areas. Given its severity and global impact, timely and accurate diagnosis is crucial for controlling its spread and improving patient outcomes.
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
134
Development of Antibiotic Resistance
Antibiotic resistance is a major public health concern that arises when bacteria evolve mechanisms to withstand the effects of antibiotic treatments. This resistance can be intrinsic, acquired through genetic mutations, or transferred between bacteria via horizontal gene transfer. The development of antibiotic resistance poses significant challenges in treating bacterial infections and necessitates ongoing research to develop new therapeutic strategies.Intrinsic resistance occurs when bacterial...
Analysis of Population Pharmacokinetic Data
235
Analysis of population pharmacokinetic data involves studying the behavior of drugs within diverse populations to understand their pharmacokinetic parameters. Traditional pharmacokinetic methods typically involve collecting samples from a few individuals and estimating these parameters. While these methods are commonly used, they have limitations in capturing the variability in drug response among individuals or heterogeneous populations. Population pharmacokinetics is employed to address these...
235


